Connecting the Right Sites to Promising Trials

The fact that clinical trial planning bottlenecks have become a significant burden for the pharmaceutical industry is well-known. The number of New Drug Application approvals by the U.S. Food and Drug Administration is declining, despite greatly increased research and development (R&D) spending. A